Abstract | AIM: METHODS: PubMed, Embase, the Cochrane Library, and Web of Science were searched to identify relevant randomized controlled trials (RCTs). Eligible trials were RCTs that compared high-dose PPI with low-dose PPI following endoscopic hemostasis. The primary endpoint was rebleeding; secondary endpoints were patient numbers that needed surgery, and mortality. The meta-analysis was performed with a fixed effects model or random effects model. RESULTS: Nine eligible RCTs including 1342 patients were retrieved. The results showed that high-dose intravenous PPI was not superior to low-dose intravenous PPI in reducing rebleeding [odds ratio (OR) = 1.091, 95% confidential interval (CI): 0.777-1.532], need for surgery (OR = 1.522, 95% CI: 0.643-3.605) and mortality (OR = 1.022, 95% CI: 0.476-2.196). Subgroup analysis according to different region revealed no difference in rebleeding rate between Asian patients (OR = 0.831, 95% CI, 0.467-1.480) and European patients (OR = 1.263, 95% CI: 0.827-1.929). CONCLUSION:
|
Authors | Liu-Cheng Wu, Yun-Fei Cao, Jia-Hao Huang, Cun Liao, Feng Gao |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 16
Issue 20
Pg. 2558-65
(May 28 2010)
ISSN: 2219-2840 [Electronic] United States |
PMID | 20503458
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Databases, Factual
- Dose-Response Relationship, Drug
- Gastrointestinal Hemorrhage
(drug therapy, mortality, prevention & control, surgery)
- Hemostasis, Endoscopic
- Humans
- Proton Pump Inhibitors
(therapeutic use)
- Randomized Controlled Trials as Topic
- Recurrence
- Upper Gastrointestinal Tract
(pathology, surgery)
|